By Counterforce Health Team in Nourianz (istradefylline) —

Renewing Nourianz (Istradefylline) Coverage with Humana in Washington: Complete Timeline and Documentation Guide

Quick Answer: Humana Medicare Advantage members in Washington should begin Nourianz renewal 60-90 days before current authorization expires. Submit updated clinical documentation showing continued "off" episodes, therapy response, and ongoing levodopa use. If denied, you have 65 days to appeal and can request external review through Washington's Independent Review Organization process. Start by checking your current authorization end date in Humana's member portal.

Table of Contents

When to Start Your Renewal

Nourianz (istradefylline) prior authorizations with Humana typically last 12 months, but renewal preparation should begin well before expiration. Here's your timing strategy:

90 Days Before Expiration:

  • Schedule neurologist appointment for updated assessment
  • Request current clinical notes and lab results
  • Review your "off" episode diary for the past 6 months

60 Days Before Expiration:

  • Submit renewal request with updated documentation
  • Confirm your neurologist has submitted supporting materials
  • Verify Nourianz remains on your plan's formulary for the upcoming year

30 Days Before Expiration:

  • Follow up if no decision received
  • Prepare bridge therapy options with your doctor
  • Consider requesting expedited review if needed
Note: Humana committed to providing decisions within one business day for 95% of electronically submitted prior authorization requests starting in 2026, but current processing may take longer.

Evidence You'll Need to Update

Your renewal success depends on demonstrating continued medical necessity. Gather these key pieces of evidence:

Clinical Response Documentation

  • Motor function assessments from the past 6 months showing ongoing "off" episodes
  • Patient diary documenting frequency and duration of "off" time
  • Quality of life measures showing functional impact
  • Adverse event monitoring records (dyskinesia, hallucinations, impulse control)

Medication History Updates

  • Continued levodopa/carbidopa use (Nourianz is only approved as adjunct therapy)
  • Dosing adjustments made during the current authorization period
  • Adherence documentation showing consistent use
  • Any new medication trials or failures since initial approval

Laboratory and Clinical Data

  • Recent neurological exam findings
  • Updated diagnosis confirmation (Parkinson's disease with "off" episodes)
  • Contraindications to alternatives if applicable
  • Smoking status (affects Nourianz metabolism and dosing)

Building Your Renewal Packet

Core Documents Checklist

  • Completed Humana prior authorization form (verify current form)
  • Updated letter of medical necessity from neurologist
  • Clinical notes from past 6 months
  • "Off" episode diary or assessment tool results
  • Current medication list with dosages
  • Previous authorization approval letter

Medical Necessity Letter Structure

Your neurologist should include:

  1. Patient identification and Parkinson's disease diagnosis (include ICD-10 code)
  2. Current symptom status with specific "off" episode documentation
  3. Response to Nourianz during current authorization period
  4. Continued need despite optimal levodopa therapy
  5. Safety monitoring results and adverse event assessment
  6. Alternative therapies tried or contraindicated
Clinician Corner: The FDA label for Nourianz specifies it's indicated "as adjunctive treatment to levodopa/carbidopa in adult patients with Parkinson's disease experiencing 'off' episodes." Your letter should directly reference this indication and demonstrate ongoing "off" episodes despite optimized levodopa therapy.

Submission Timeline and Decision Windows

Submission Method Processing Time Best For
Electronic (provider portal) 1-7 business days Routine renewals
Fax submission 7-14 business days When portal unavailable
Expedited request 24-72 hours Urgent clinical need

Standard Process:

  1. Day 1: Submit complete renewal packet
  2. Days 1-7: Humana clinical review
  3. Day 7: Decision notification (approval/denial/more info needed)
  4. Days 8-14: Additional documentation period if requested

If Additional Information Requested:

  • Respond within 14 days to avoid automatic denial
  • Common requests: recent clinic notes, updated "off" episode documentation, peer-to-peer review

If Your Coverage Lapses

Immediate Bridge Options

If your Nourianz authorization expires before renewal approval, discuss these alternatives with your neurologist:

COMT Inhibitors (often preferred on formulary):

  • Entacapone (Comtan) - extends levodopa duration
  • Tolcapone (Tasmar) - requires liver monitoring

MAO-B Inhibitors:

  • Rasagiline (Azilect) - once daily dosing
  • Selegiline - multiple formulations available

Other Adjuncts:

  • Amantadine - especially if dyskinesia present
  • Dopamine agonists - if tolerated

Cost Assistance During Gaps

  • Nourianz patient assistance program may provide temporary coverage
  • Copay cards can reduce out-of-pocket costs for eligible patients
  • Some patients may qualify for manufacturer bridge programs

Annual Plan Changes to Monitor

Formulary Updates

Humana updates formularies monthly and makes significant changes annually. Monitor for:

  • Tier changes affecting your copay/coinsurance
  • New step therapy requirements added to Nourianz
  • Quantity limit modifications
  • Site of care restrictions (specialty pharmacy requirements)

Coverage Structure Changes

For 2025, Humana Medicare Advantage plans in Washington are implementing significant cost-sharing changes:

  • Preferred brand drugs: Coinsurance increases from 2% to 28% of enrollees
  • Non-preferred drugs: Coinsurance increases from 11% to 57% of enrollees
Important: During Medicare's open enrollment (October 15 - December 7), verify Nourianz coverage and cost-sharing for the following year.

Personal Renewal Tracker

Use this template to track your renewal progress:

Current Authorization Details:

  • Approval date: ___________
  • Expiration date: ___________
  • Current dose: ___________
  • Prescribing neurologist: ___________

Renewal Timeline:

  • 90 days out: Scheduled neurologist appointment (Date: _______)
  • 60 days out: Submitted renewal packet (Date: _______)
  • Decision received (Date: _______ Result: _______)
  • If denied, appeal filed (Date: _______)

Documentation Status:

  • Updated clinical notes obtained
  • "Off" episode diary completed
  • Medical necessity letter requested
  • All forms submitted to Humana

Appeals Process for Washington Members

If your renewal is denied, Washington residents have strong appeal rights:

Internal Appeals (Required First Steps)

  1. Level 1 Redetermination: File within 65 days of denial
  2. Level 2 Reconsideration: File within 60 days if Level 1 denied

External Review Options

Washington law provides additional protection through Independent Review Organizations (IROs):

From our advocates: "We've seen many Nourianz renewals initially denied for 'insufficient documentation' get approved on appeal when the neurologist provides a detailed letter explaining why the patient still experiences 'off' episodes despite optimal levodopa therapy. The key is showing continued medical necessity with specific clinical examples, not just stating the patient 'is doing well' on the medication."

Expedited Appeals

Request expedited review if:

  • Your health could be seriously jeopardized by delay
  • You're currently stable on Nourianz and interruption could cause harm
  • Standard timeline would cause significant symptom worsening

For expedited appeals: Humana must decide within 72 hours, and external review decisions come within 72 hours if needed.

FAQ

How long does Humana prior authorization renewal take in Washington? Standard processing is 1-7 business days for electronic submissions, up to 14 days for paper/fax submissions. Expedited reviews are completed within 72 hours when medically necessary.

What if Nourianz becomes non-formulary on my plan? You can request a formulary exception with medical necessity documentation. If your current authorization is active, Humana typically provides a transition period to switch plans or obtain an exception.

Can I request an expedited renewal? Yes, if delaying treatment could seriously jeopardize your health. Your neurologist must provide clinical justification for the expedited timeline.

Does step therapy apply to renewals? Generally no, if you're already established on Nourianz with documented efficacy. However, if there's been a significant gap in therapy, new step therapy requirements may apply.

What counts as adequate "off" episode documentation? Patient diaries showing frequency and duration of "off" time, validated assessment tools like the Parkinson's Disease Questionnaire (PDQ-39), or clinical notes documenting motor fluctuations despite optimized levodopa therapy.

How do I know if my neurologist submitted the right documentation? Request a copy of the medical necessity letter before submission. It should specifically address continued "off" episodes, response to current Nourianz therapy, and why alternatives aren't suitable.

What if I can't afford Nourianz during an appeal? Contact Kyowa Kirin Cares for patient assistance programs. Some patients may qualify for free medication during coverage gaps.

Counterforce Health specializes in turning insurance denials into successful appeals by creating evidence-backed, payer-specific submissions. Our platform analyzes denial letters and plan policies to craft targeted rebuttals that address each payer's specific requirements, helping patients get medications like Nourianz approved faster. Learn more at www.counterforcehealth.org.

When managing Nourianz renewals with Humana, early preparation and comprehensive documentation are your best tools for success. Washington's strong consumer protection laws provide additional appeal options if initial requests are denied, giving you multiple pathways to maintain coverage for this important Parkinson's disease therapy.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and review your specific insurance policy for the most current requirements. For personalized assistance with insurance appeals in Washington, contact the Washington State Office of the Insurance Commissioner at 1-800-562-6900.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.